Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report

A. Cuneo, G.M. Rigolin, M. Coscia, G. Quaresmini, L. Scarfò, F.R. Mauro, M. Motta, F.M. Quaglia, L. Trentin, A. Ferrario, L. Laurenti, G. Reda, A. Ferrari, D. Pietrasanta, P. Sportoletti, F. Re, L. De Paoli, M. Foglietta, A. Giordano, M. MarchettiL. Farina, G. Del Poeta, M. Varettoni, F. Chiurazzi, R. Marasca, L. Malerba, A. Ibatici, M.C. Tisi, V. Stefoni, M. Leone, C. Baratè, J. Olivieri, R. Murru, M. Gentile, A. Sanna, A. Gozzetti, V. Gattei, D. Gottardi, E. Derenzini, L. Levato, L. Orsucci, G. Penna, A. Chiarenza, R. Foà

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)570-574
JournalHematological Oncology
Volume39
Issue number4
DOIs
Publication statusPublished - 2021

Keywords

  • chronic lymphocytic leukemia
  • COVID-19
  • targeted agents
  • vaccination

Cite this